Luminary Groupโ€™s Post

View organization page for Luminary Group, graphic

18,858 followers

๐—œ๐—ฑ๐—ฒ๐—ฎ๐˜†๐—ฎ ๐˜€๐—ต๐—ผ๐˜„๐—ฐ๐—ฎ๐˜€๐—ฒ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—ผ๐—ณ-๐—ผ๐—ณ-๐—ฐ๐—ผ๐—ป๐—ฐ๐—ฒ๐—ฝ๐˜ ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ถ๐—ป ๐—ฎ ๐—ฏ๐—ผ๐—ผ๐˜€๐˜ ๐˜๐—ผ ๐˜€๐˜†๐—ป๐˜๐—ต๐—ฒ๐˜๐—ถ๐—ฐ ๐—น๐—ฒ๐˜๐—ต๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ฝ๐—น๐—ฎ๐˜† Fresh Phase 2 data are adding weight to Ideaya IDEAYA Biosciences case for a targeted therapy it believes could be a first-in-class treatment option for certain โ€ฆYujiro S. H. https://lnkd.in/d-wViywi

Ideaya Biosciences reports Phase 2 data for MAT2A inhibitor IDE397

Ideaya Biosciences reports Phase 2 data for MAT2A inhibitor IDE397

https://endpts.com

To view or add a comment, sign in

Explore topics